Envoy Medical Stock Alpha and Beta Analysis

COCH Stock   0.75  0.07  10.29%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Envoy Medical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Envoy Medical over a specified time horizon. Remember, high Envoy Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Envoy Medical's market risk premium analysis include:
Beta
1.15
Alpha
0.14
Risk
14.08
Sharpe Ratio
0.0491
Expected Return
0.69
Please note that although Envoy Medical alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Envoy Medical did 0.14  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Envoy Medical stock's relative risk over its benchmark. Envoy Medical has a beta of 1.15  . Envoy Medical returns are very sensitive to returns on the market. As the market goes up or down, Envoy Medical is expected to follow. The current Book Value Per Share is estimated to decrease to -1.05. The current Tangible Book Value Per Share is estimated to decrease to -1.05.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Envoy Medical Backtesting, Envoy Medical Valuation, Envoy Medical Correlation, Envoy Medical Hype Analysis, Envoy Medical Volatility, Envoy Medical History and analyze Envoy Medical Performance.
For more detail on how to invest in Envoy Stock please use our How to Invest in Envoy Medical guide.

Envoy Medical Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Envoy Medical market risk premium is the additional return an investor will receive from holding Envoy Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Envoy Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Envoy Medical's performance over market.
α0.14   β1.15

Envoy Medical expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Envoy Medical's Buy-and-hold return. Our buy-and-hold chart shows how Envoy Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Envoy Medical Market Price Analysis

Market price analysis indicators help investors to evaluate how Envoy Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Envoy Medical shares will generate the highest return on investment. By understating and applying Envoy Medical stock market price indicators, traders can identify Envoy Medical position entry and exit signals to maximize returns.

Envoy Medical Return and Market Media

The median price of Envoy Medical for the period between Fri, Sep 26, 2025 and Thu, Dec 25, 2025 is 0.81 with a coefficient of variation of 15.11. The daily time series for the period is distributed with a sample standard deviation of 0.12, arithmetic mean of 0.8, and mean deviation of 0.07. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
09/30/2025
2
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim Cochlear Implant Pivotal Clinical Trial
11/04/2025
3
Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery
11/20/2025
4
Envoy Medical Announces the Grant of Its 40th U.S. Patent
12/02/2025
5
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim Cochlear Implant
12/10/2025

About Envoy Medical Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Envoy or other stocks. Alpha measures the amount that position in Envoy Medical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2024 2025 (projected)
Dividend Yield0.0820.0729
Price To Sales Ratio119.42113.45

Envoy Medical Upcoming Company Events

As portrayed in its financial statements, the presentation of Envoy Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Envoy Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Envoy Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Envoy Medical. Please utilize our Beneish M Score to check the likelihood of Envoy Medical's management manipulating its earnings.
16th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
16th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Envoy Medical

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Envoy Medical is a strong investment it is important to analyze Envoy Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Envoy Medical's future performance. For an informed investment choice regarding Envoy Stock, refer to the following important reports:
Check out Envoy Medical Backtesting, Envoy Medical Valuation, Envoy Medical Correlation, Envoy Medical Hype Analysis, Envoy Medical Volatility, Envoy Medical History and analyze Envoy Medical Performance.
For more detail on how to invest in Envoy Stock please use our How to Invest in Envoy Medical guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Envoy Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Envoy Medical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Envoy Medical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...